TIM
MNTA

Tortoise Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Tortoise Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6,725
Closed -$138K – 581
2018
Q2 		$138K Hold
6,725
– – 0.04% 161
2018
Q1 		$122K Hold
6,725
– – 0.03% 166
2017
Q4 		$94K Hold
6,725
– – 0.03% 191
2017
Q3 		$124K Hold
6,725
– – 0.04% 155
2017
Q2 		$114K Buy
+6,725
New +$102K 0.04% 150

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tortoise Investment Management's MNTA Position: Q3 2018 in Review

Tortoise Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2018, closing a stake of 6,725 shares — an estimated $138K sold.

Tortoise Investment Management first reported a position in MNTA in Q2 2017 and held it in 5 quarters. The position peaked at $138K in Q2 2018. 159 funds tracked by Wall St. Rank hold MNTA as of Q3 2018.

  • Tortoise Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Tortoise Investment Management sold 6,725 Momenta Pharmaceuticals, Inc. shares in Q3 2018, an estimated $138K.
  • Tortoise Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2017 and held it in 5 quarters.
  • Tortoise Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $138K in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2018.

Based on Tortoise Investment Management's 13F filing for Q3 2018, filed 20 Nov 2018.